Dicerna Pharmaceuticals, Inc. Operating Income 2013-2021 | DRNA

Dicerna Pharmaceuticals, Inc. operating income from 2013 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Dicerna Pharmaceuticals, Inc. Annual Operating Income
(Millions of US $)
2020 $-113
2019 $-128
2018 $-90
2017 $-61
2016 $-60
2015 $-63
2014 $-45
2013 $-17
2012 $-9
2011 $-8
Dicerna Pharmaceuticals, Inc. Quarterly Operating Income
(Millions of US $)
2021-09-30 $-20
2021-06-30 $-40
2021-03-31 $-29
2020-12-31 $-32
2020-09-30 $-23
2020-06-30 $-33
2020-03-31 $-25
2019-12-31 $-41
2019-09-30 $-33
2019-06-30 $-26
2019-03-31 $-28
2018-12-31 $-19
2018-09-30 $-19
2018-06-30 $-36
2018-03-31 $-16
2017-12-31 $-17
2017-09-30 $-15
2017-06-30 $-15
2017-03-31 $-14
2016-12-31 $-14
2016-09-30 $-14
2016-06-30 $-16
2016-03-31 $-16
2015-12-31 $-16
2015-09-30 $-17
2015-06-30 $-16
2015-03-31 $-14
2014-12-31 $-15
2014-09-30 $-11
2014-06-30 $-11
2014-03-31 $-8
2013-12-31 $-6
2013-09-30 $-4
2013-06-30 $-4
2013-03-31 $-4
2012-09-30